FLAVORx Increases Production of Flavorings for Tamiflu in Preparation for Avian Flu

FLAVORx Inc, the company that sets the gold-standard for scientifically-tested and specifically designed medicinal flavorings, has announced that it will increase production to supplement consumer demand. As a result of heightened awareness of an impending avian flu outbreak, parents, doctors and pharmacists alike want to ensure that their children and patients are able to swallow antiviral medications that will be used to treat the virus.

Bethesda, MD. (PRWEB) March 22, 2006 -- FLAVORx CFO Woodie Neiss announced today that the company will increase production of its medicinal flavorings by over 30% in response to a growing demand set in motion by Americans preparing for an avian flu pandemic.

For the past several months, the company has received countless calls from concerned parents, doctors and pharmacists who fear the bitter taste of Tamiflu will prevent their children from receiving a potentially life-saving medication. In advance of this viral spread that experts now predict is certain to hit the US, FLAVORx is prepared to stockpile its flavorings and make them readily available for mass distribution. Compliance is a key issue that determines the how well a medication works. Oftentimes, young children are unable to swallow liquid medications due to unpalatable taste or unpleasant smell. These concerns are alleviated with the use of FLAVORx, a medicinal flavoring system that can be used to flavor over-the-counter or prescription medications. Since there is such a disparity in children's sense of taste there are over 42 flavors to choose from to help ease the trauma associated with illness and medication.

For more information, please visit www.flavorx.com or contact Teresa Chen at 800.884.5771, extension 234.

###


Contact Information
Teresa Chen
FLAVORX, INC.
http://www.flavorx.com
240.223.0953

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy